Lexicon Pharmaceuticals, Inc. - LXRX Quarterly Revenue Growth

lexpharma.com (LXRX) - corporate logo

Lexicon Pharmaceuticals production capacities are fully optimized for the manufacture of metabolic agents. Revenues are based on the sale of patented drugs through insurance funds and government programs. Quarterly sales growth with a metric value of -20.80 confirms the commercialization potential of Inpefa, making the expansion of insurance coverage and the FDA verdict key catalysts for the asset's value growth.

LXRX Lexicon Pharma Quarterly Sales Growth Rate (07/04/2022 - 11/20/2026)

Lexicon Pharmaceuticals, Inc. - analytical breakdowns and key metrics (LXRX)

- current quotes and average value forecast:
- cash and cash flow indicators:
Mass-produced product of lexpharma.com

Lexicon Pharmaceuticals (LXRX) revenues depend on insurance reimbursements for high-cost drugs treating cardiac and endocrine pathologies. By analyzing the QoQ revenue growth rate, an investor assesses the real dynamics of the company's market expansion. This metric measures the speed of cash inflows between quarters, allowing one to filter out market noise and identify the true phase of the operating cycle. Such indicators are critical for evaluating the fundamental value of biotechnological assets.

Direct competitors

ASND - Revenue Growth QoQ|MDGL: Revenue Growth QoQ|CORT: Quarterly Revenue Growth|RYTM - Quarterly Sales Growth Rate|Revenue Growth QoQ Akero Corp|Metsera Therapeutics (MTSR) - Quarterly Sales Growth Rate|Revenue Growth QoQ moonlaketx.com (MLTX)|Quarterly Sales Growth Crinetics Pharmaceuticals CRNX|Revenue Growth QoQ NewAmsterdam Pharma N.V. NAMS|Quarterly Sales Growth Rate Soleno Therapeutics Inc (SLNO)|FOLD - Revenue Growth QoQ|ETNB: Revenue Growth QoQ|AGIO: Quarterly Revenue Growth|Structure Therapeutics Inc. - Quarterly Revenue Increase|MDXG (MiMedx Corp) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Rezolute Inc RZLT|Quarterly Revenue Growth MBX|Quarterly Sales Growth Altimmune, Inc. ALT|Quarterly Revenue Growth AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Quarterly Revenue Growth Rate|BIOA: Quarterly Sales Growth|Quarterly Revenue Increase BMEA (Biomea Fusion)|QNCX (quincetx.com) - Quarterly Sales Growth|Fractyl - Quarterly Revenue Increase|VTVT (vTv Therapeutics Inc) - Quarterly Revenue Growth|Agape ATP - Revenue Dynamics QoQ|Quarterly Sales Growth PLUR (Pluri Inc)|Quarterly Sales Growth Rate Synlogic Inc.|Revenue Growth QoQ Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Quarterly Revenue Growth Rate|Spruce Biosciences Inc. - Quarterly Revenue Growth|Quarterly Sales Growth Rate Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Revenue Growth QoQ|Lumos Pharma - Quarterly Revenue Increase|ONVO (Organovo Corp) - Quarterly Revenue Growth|Radius Pharmaceuticals (RDUS) - Quarterly Sales Growth Rate